We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
17 hedge funds and large institutions have $998K invested in COSCIENS Biopharma Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
58% more capital invested
Capital invested by funds: $633K → $998K (+$365K)
0% more funds holding
Funds holding: 17 → 17 (0)
0% more ownership
Funds ownership: 0.05% → 0.05% (+0%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
+$16K
Top Buyers
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$18.3K |
| 2 |
Jane Street
New York
|
+$14.8K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$3.84K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$824 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$641 |
Top Sellers
| 1 |
BlackRock
New York
|
-$26K |
| 2 |
Morgan Stanley
New York
|
-$18.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$366 |
